- Recommendation ID
- NG243/4
- Question
What is the clinical and cost effectiveness of glucocorticoids for the routine management of secondary and tertiary adrenal insufficiency?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on routine pharmacological management .
Full details of the evidence and the committee's discussion are in evidence review G: routine pharmacological management of secondary and tertiary adrenal insufficiency.
Source guidance details
- Comes from guidance
- Adrenal insufficiency: identification and management
- Number
- NG243
- Date issued
- August 2024
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 28/01/2025 |